A comparison of contraceptive procurement pre- and post-benefit change

Contraception. 2007 Nov;76(5):360-5. doi: 10.1016/j.contraception.2007.07.006.

Abstract

Background: In 2002, the Kaiser Foundation Health Plan in California changed its coverage policy to include 100% universal coverage for the most effective forms of contraception and for emergency contraceptive pills (ECPs). This study sought to evaluate whether removing the cost of contraception as a potential barrier to utilization would lead to a change in the mix of contraceptive methods prescribed and purchased by a large health plan and whether those changes could theoretically result in averting a greater number of unintended pregnancies.

Study design: A retrospective observational study was conducted to describe the mix of reversible contraceptives procured before and after the benefit change at Kaiser Permanente Northern California. We then estimated couple-years of protection (CYP) to examine whether the contraceptive mix changed to more effective reversible methods.

Results: After the contraceptive benefit change, CYP increased by 28% (from 2001-2002 to 2003-2004), while the number of females aged 15-44 enrolled in this health plan fell by 1%. CYP for intrauterine contraceptives (IUCs) and injectables rose by 137% and 32%, respectively, while CYP for the pill, patch and ring rose only by 16%. The estimated average annual contraceptive failure rate among women using hormonal contraceptives and IUCs declined from 7.0% to 6.4%. Purchasing of the ECP rose by 88%.

Conclusion: Removal of the cost of contraception may result in increased utilization of more effective methods and ECPs.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Contraceptive Agents, Female / economics*
  • Contraceptive Agents, Female / supply & distribution
  • Contraceptive Devices, Female / economics*
  • Contraceptive Devices, Female / statistics & numerical data
  • Contraceptive Devices, Female / supply & distribution
  • Female
  • Humans
  • Insurance Benefits / economics
  • Managed Care Programs / statistics & numerical data
  • Pregnancy, Unplanned
  • Retrospective Studies

Substances

  • Contraceptive Agents, Female